1. Home
  2. NEO vs MXL Comparison

NEO vs MXL Comparison

Compare NEO & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • MXL
  • Stock Information
  • Founded
  • NEO 2001
  • MXL 2003
  • Country
  • NEO United States
  • MXL United States
  • Employees
  • NEO N/A
  • MXL N/A
  • Industry
  • NEO Precision Instruments
  • MXL Semiconductors
  • Sector
  • NEO Health Care
  • MXL Technology
  • Exchange
  • NEO Nasdaq
  • MXL Nasdaq
  • Market Cap
  • NEO 1.2B
  • MXL 1.1B
  • IPO Year
  • NEO 1999
  • MXL 2010
  • Fundamental
  • Price
  • NEO $9.62
  • MXL $10.99
  • Analyst Decision
  • NEO Strong Buy
  • MXL Buy
  • Analyst Count
  • NEO 10
  • MXL 7
  • Target Price
  • NEO $19.78
  • MXL $25.58
  • AVG Volume (30 Days)
  • NEO 1.5M
  • MXL 1.5M
  • Earning Date
  • NEO 04-29-2025
  • MXL 04-23-2025
  • Dividend Yield
  • NEO N/A
  • MXL N/A
  • EPS Growth
  • NEO N/A
  • MXL N/A
  • EPS
  • NEO N/A
  • MXL N/A
  • Revenue
  • NEO $660,566,000.00
  • MXL $360,528,000.00
  • Revenue This Year
  • NEO $12.89
  • MXL $24.50
  • Revenue Next Year
  • NEO $11.36
  • MXL $19.87
  • P/E Ratio
  • NEO N/A
  • MXL N/A
  • Revenue Growth
  • NEO 11.65
  • MXL N/A
  • 52 Week Low
  • NEO $8.98
  • MXL $10.86
  • 52 Week High
  • NEO $19.11
  • MXL $26.59
  • Technical
  • Relative Strength Index (RSI)
  • NEO 41.15
  • MXL 31.66
  • Support Level
  • NEO $9.57
  • MXL $12.40
  • Resistance Level
  • NEO $10.37
  • MXL $13.50
  • Average True Range (ATR)
  • NEO 0.65
  • MXL 0.61
  • MACD
  • NEO 0.13
  • MXL 0.08
  • Stochastic Oscillator
  • NEO 31.79
  • MXL 4.92

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

Share on Social Networks: